Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY
No-Receipt date
2017-02188 - 26/06/2017
No-Filing date
20170401732 - 26/06/2017
No-Granting date
3092885 - 07/09/2017
No-EPO application date
10794668.3 - 29/06/2010
No-EPO granting date
2448582 - 19/04/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
9/2017 - 22/11/2017
Expiration date
30/06/2030
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US292360 P05/01/2010/US
US221430 P29/06/2009/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/497
A61K 31/5513
A61P 35/00
C07D 215/36
C07D 215/40
C07D 239/42
C07D 241/20
C07D 243/08
C07D 271/12
C07D 277/64
C07D 277/68
C07D 295/192
C07D 319/18
C07D 401/12
C07D 401/14
C07D 403/12
C07D 407/12
C07D 409/12
C07D 417/12
C07D 417/14
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20230800007
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
779202
AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE, MA 02139
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1919705
SAUNDERS, JEFFREY, O.
1919706
SALITURO, FRANCESCO, G.
1919707
YAN, SHUNQI
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).